(Q43550137)

24 November 2017

title

Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children (English)

1 reference

24 November 2017

0 references

dilated cardiomyopathy

1 reference

Idiopathic dilated cardiomyopathy

inferred from title

1 reference

Venugopalan P

1

1 reference

24 November 2017

Agarwal AK

2

1 reference

24 November 2017

Akinbami FO

3

1 reference

24 November 2017

El Nour IB

4

1 reference

24 November 2017

Subramanyan R

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

International Journal of Cardiology

24 November 2017

published in

1 reference

24 November 2017

volume

65

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

125-128

1 reference

Dilated cardiomyopathy: an introduction to pathology and pathogenesis

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Identification and management of the high risk patient with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Treatment of end stage dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Dilated cardiomyopathy in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Dilated cardiomyopathy in children: determinants of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Link between enteroviruses and dilated cardiomyopathy: serological and molecular data

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Role of autoimmunity in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Familial dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Natural history of dilated cardiomyopathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Clinical course of idiopathic dilated cardiomyopathy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Outcome of infants and children with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2898%2900084-9

7 January 2021

10.1016/S0167-5273(98)00084-9

Identifiers

DOI

1 reference

24 November 2017

1 reference